If a variant has more than one submission, it may be counted in more than one significance column. If this is the
case, the total number of variants will be less than the sum of the other cells.
pathogenic |
likely pathogenic |
uncertain significance |
likely benign |
benign |
total |
64
|
41
|
50
|
0 |
0 |
155
|
Gene and significance breakdown #
Total genes and gene combinations: 28
Gene or gene combination |
pathogenic |
likely pathogenic |
uncertain significance |
total |
SOX5
|
22
|
2
|
4
|
28
|
SYN1
|
14
|
2
|
6
|
22
|
RNU4-2, SIRT4
|
5
|
12
|
4
|
21
|
CHD5
|
0 |
16
|
1
|
17
|
ANKRD11
|
13
|
3
|
0 |
16
|
LOC130057317, RNU5B-1
|
0 |
3
|
7
|
10
|
KCNN2, LOC101927078
|
4
|
2
|
0 |
6
|
RNU5A-1
|
0 |
0 |
5
|
5
|
KCNN2
|
3
|
1
|
0 |
4
|
ARMH1, RNU5F-1
|
0 |
0 |
3
|
3
|
LOC107985108, RNVU1-18
|
0 |
0 |
2
|
2
|
LOC113939979, RNVU1-15
|
0 |
0 |
2
|
2
|
RNU1-2
|
0 |
0 |
2
|
2
|
RNU6-2
|
0 |
0 |
2
|
2
|
RNVU1-14
|
0 |
0 |
2
|
2
|
intergenic
|
0 |
0 |
1
|
1
|
BCAT1, LINC02909, SOX5
|
1
|
0 |
0 |
1
|
CLASP1, RNU4ATAC
|
0 |
0 |
1
|
1
|
LOC129929420, RNU5E-1
|
0 |
0 |
1
|
1
|
LOC129931314, RNVU1-19
|
0 |
0 |
1
|
1
|
LOC129931365, RNVU1-27
|
0 |
0 |
1
|
1
|
MARCHF6
|
1
|
0 |
0 |
1
|
RNU4-1, RNU4-2, SIRT4
|
1
|
0 |
0 |
1
|
RNU4-1, SIRT4
|
0 |
0 |
1
|
1
|
RNU5E-1
|
0 |
0 |
1
|
1
|
RNU6-8
|
0 |
0 |
1
|
1
|
RNU6-9
|
0 |
0 |
1
|
1
|
RNU6ATAC
|
0 |
0 |
1
|
1
|
Condition and significance breakdown #
Condition |
pathogenic |
likely pathogenic |
uncertain significance |
total |
not provided
|
0 |
0 |
35
|
35
|
Lamb-Shaffer syndrome
|
23
|
2
|
0 |
25
|
Neurodevelopmental disorder with hypotonia, brain anomalies, distinctive facies, and absent language
|
6
|
12
|
4
|
22
|
Global developmental delay
|
14
|
6
|
0 |
20
|
Epilepsy, X-linked 1, with variable learning disabilities and behavior disorders
|
12
|
1
|
5
|
18
|
Global developmental delay; Seizure; Intellectual disability
|
0 |
5
|
0 |
5
|
Global developmental delay; Intellectual disability
|
0 |
3
|
1
|
4
|
Intellectual disability, X-linked 50
|
2
|
1
|
1
|
4
|
Intellectual disability
|
0 |
0 |
3
|
3
|
RNU5B-1 related disorder
|
0 |
3
|
0 |
3
|
Seizure
|
0 |
3
|
0 |
3
|
Global developmental delay; Seizure
|
0 |
2
|
0 |
2
|
Cerebellar ataxia; Global developmental delay; Autistic behavior; Intellectual disability
|
0 |
1
|
0 |
1
|
Cerebellar ataxia; Global developmental delay; Dyskinesia; Intellectual disability, mild
|
1
|
0 |
0 |
1
|
Cerebellar ataxia; Global developmental delay; Intellectual disability, mild
|
1
|
0 |
0 |
1
|
Epilepsy, familial adult myoclonic, 3
|
1
|
0 |
0 |
1
|
Global developmental delay; Autistic behavior; Intellectual disability, moderate
|
1
|
0 |
0 |
1
|
Global developmental delay; Autistic behavior; Intellectual disability, severe; Motor tics
|
1
|
0 |
0 |
1
|
Global developmental delay; Autistic behavior; Intellectual disability; Motor tics
|
0 |
1
|
0 |
1
|
Global developmental delay; Autistic behavior; Seizure; Intellectual disability, mild
|
1
|
0 |
0 |
1
|
Global developmental delay; Autistic behavior; Seizure; Intellectual disability, moderate
|
0 |
1
|
0 |
1
|
Global developmental delay; Intellectual disability; Bradykinesia; Motor tics
|
1
|
0 |
0 |
1
|
Tourette syndrome
|
0 |
0 |
1
|
1
|
The information on this website is not intended for direct
diagnostic use or medical decision-making without review by a
genetics professional. Individuals should not change their
health behavior solely on the basis of information contained on
this website. Neither the University of Utah nor the National
Institutes of Health independently verfies the submitted
information. If you have questions about the information
contained on this website, please see a health care
professional.